Alkermes
ALKS
#2443
Rank
NZ$13.44 B
Marketcap
NZ$80.14
Share price
-3.05%
Change (1 day)
60.73%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2026 (TTM): NZ$0.40 Billion

According to Alkermes's latest financial reports the company's current earnings are NZ$1.56 Billion. In 2025 the company made an earning of NZ$0.51 Billion a decrease over its 2024 earnings that were of NZ$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.40 B-22.07%
2025 NZ$0.51 B-34.87%
2024 NZ$0.78 B-17.97%
2023 NZ$0.96 B-468.52%
2022 -NZ$0.27 Billion449.24%
2021 -NZ$47.48 Million-68.04%
2020 -NZ$0.15 Billion-52.1%
2019 -NZ$0.32 Billion64.49%
2018 -NZ$0.19 Billion-15.04%
2017 -NZ$0.23 Billion-34.2%
2016 -NZ$0.34 Billion-5.34%
2015 -NZ$0.36 Billion35084.97%
2014 -NZ$1.02 Million
2012 NZ$12.54 M-117.81%
2011 -NZ$70.46 Million-12.69%
2010 -NZ$80.7 Million94.3%
2009 -NZ$41.54 Million-117.7%
2008 NZ$0.23 B622.63%
2007 NZ$32.47 M
2004 -NZ$0.13 Billion-14.48%
2003 -NZ$0.16 Billion11.88%
2002 -NZ$0.14 Billion39.65%
2001 -NZ$96.12 Million5.73%
2000 -NZ$90.9 Million-28.91%
1999 -NZ$0.13 Billion237.28%
1998 -NZ$37.91 Million100.05%
1997 -NZ$18.95 Million-37.93%
1996 -NZ$30.53 Million82.72%
1995 -NZ$16.71 Million-26.79%
1994 -NZ$22.82 Million-72.78%
1993 -NZ$83.84 Million208.07%
1992 -NZ$27.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.91 B 10,852.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$26.67 B 6,554.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$17.90 B 4,364.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.94 B 3,128.65%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$16.22 B 3,945.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$24.78 B 6,082.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-NZ$0.36 Billion-189.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.46 Billion-214.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.83 B 857.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel